Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (837)	5/13/1998 9:09:00 AM
From: Bob Trocchi	Read Replies (3) \| Respond to of 4634

Bill... RE: ZONA I received an analyst's recommendation today on ZONA. BTW, I am short and intend to stay short. The recommendation cites a discussion the analyst (Matt Geller from CIBC OPCO whomever they are) had with a Dr. Irwin Goldstein, Prof. Of Urology at Boston Univ. Without typing in all the material, the bottom line is that Dr. Goldstein and I quote here "supports potential benefits of Vasomax in women." Bottom line, based on his discussion, Geller has raised EPS for ZONA to 0.09 in 99 and 0.85 on 00 and 3.37 in 01 with target price of ZONA of $50 and issues a buy recommendation. Question: have you ever heard of either Dr. Goldstein or Matt Geller. Are they part of the scam of trying to pump this up. I do not believe any of the above but this is the type of info. that hooks the unsuspecting investor and keeps the price at an inflated value. Thanks Bob Trocchi